Phibro Animal Health (PAHC) Tops Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corporation Reports First Quarter
November 11, 2014 4:15 PM ESTTEANECK, N.J., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its first quarter ended September 30, 2014. It also updated guidance for its fiscal year ending June 30, 2015.
Highlights for the September 2014 quarter (compared to the September 2013 quarter) Net sales of $187 million, an increase of 16% Adjusted EBITDA of $30 million, an increase of 41% Adjusted diluted EPS of $0.51 Â Â Â Â Guidance for the June 2015 fiscal year (compared to the June 2014 fiscal year) updated to reflect an increase of $4 million attributable to accelerated licensing revenue and profit for... More


